RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ana M. Espino to Disease Models, Animal

This is a "connection" page, showing publications Ana M. Espino has written about Disease Models, Animal.
Connection Strength

0.658
  1. Armina-Rodriguez A, Dorta-Estremera SM, Mendez LB, Espino AM. Protection of mice against septic shock induced by lethal intraperitoneal dose of LPS by a recombinant Fasciola hepatica fatty acid binding protein. Microbiol Spectr. 2026 Apr 07; 14(4):e0275625.
    View in: PubMed
    Score: 0.160
  2. Figueroa-Gispert MDM, Ramos-Lugo CM, Ocasio-Malav? C, Scott RP, Ahrendsen JT, Gomez-Samblas M, Osuna A, Dorta-Estremera SM, Espino AM. Fh15 Reduces Colonic Inflammation and Leukocyte Infiltration in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model. Cells. 2025 05 29; 14(11).
    View in: PubMed
    Score: 0.151
  3. Aguayo V, Vald?s Fernandez BN, Rodr?guez-Valent?n M, Ruiz-Jim?nez C, Ramos-Ben?tez MJ, M?ndez LB, Espino AM. Fasciola hepatica GST downregulates NF-?B pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model. Sci Rep. 2019 02 19; 9(1):2275.
    View in: PubMed
    Score: 0.098
  4. Ramos-Benitez MJ, Ruiz-Jimenez C, Rosado-Franco JJ, Ramos-P?rez WD, Mendez LB, Osuna A, Espino AM. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock. mSphere. 2018 12 19; 3(6).
    View in: PubMed
    Score: 0.097
  5. Gaudier JF, Cab?n-Hern?ndez K, Osuna A, Espino AM. Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica. Clin Vaccine Immunol. 2012 Mar; 19(3):325-33.
    View in: PubMed
    Score: 0.060
  6. Espino AM, Rivera F. Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis. Vet Parasitol. 2010 Apr 19; 169(1-2):82-92.
    View in: PubMed
    Score: 0.052
  7. Figueroa-Gispert MDM, Mel?ndez-V?zquez NM, Espino AM, Godoy-Vitorino F. Intermittent Administration of Helminth-Derived Fh15 Modulates Gut Microbiota and Partially Mitigates Dysbiosis in Early Stages of Severe Experimental Colitis. Int J Mol Sci. 2026 May 02; 27(9).
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support